miR-15b and miR-21 as Circulating Biomarkers for Diagnosis of Glioma

Title:miR-15b and miR-21 as Circulating Biomarkers for Diagnosis of Glioma

Volume: 16 Issue: 5

Author(s): Pietro Ivo D’Urso, Oscar Fernando D’Urso, Cosimo Damiano Gianfreda, Valeria Mezzolla, Carlo Storelli and Santo Marsigliante

Affiliation:

Keywords: Biomarkers, Blood, Diagnosis, Glioma, Microarrays, miRNAs.

Abstract: Malignant gliomas are lethal primary intracranial tumors. To date, little information on the role of deregulated genes in gliomas have been identified. As the involvement of miRNAs in the carcinogenesis is well known, we carried out a pilot study to identify, as potential biomarkers, differentially expressed microRNAs in blood samples of patients affected by glioma. We studied the miRNAs’ expression, by means of microarray and Real-Time PCR, in 30 blood samples from glioma patients and in 82 blood samples of patients suffering from: (a) various neurological disorders (n=30), (b) primary B-lymphoma of the Central Nervous System (PCNSL, n=36) and (c) secondary brain metastases (n=16). By quantitative real time reverse-transcriptase polymerase chain reaction (qRT-PCR), we identified significantly increased levels of two candidate biomarkers, miR-15b and miR-21, in blood of patients affected by gliomas. ROC analysis of miR-15b biomarker levels allowed to differentiate patients with tumour from patients without glioma. Furthermore, combined expression analyses of miR15b and miR-21 distinguished between patients with and without glioma (90% sensitivity and 100% specificity). In addition, a decrement in the expression levels of miR-16 characterized glioblastomas compared to low grade and anaplastic gliomas. In conclusion, this pilot study suggest that it’s possible to identify the disease state by meaning miR-15b and miR-21 markers in blood, while miR-16 can be used to distinguish glioblastoma from other grade gliomas. They can potentially be used as biomarkers for non-invasive diagnosis of gliomas; further studies are mandatory to confirm our preliminary findings.

Cite this article as:

Ivo D’Urso Pietro, Fernando D’Urso Oscar, Damiano Gianfreda Cosimo, Mezzolla Valeria, Storelli Carlo and Marsigliante Santo, miR-15b and miR-21 as Circulating Biomarkers for Diagnosis of Glioma, Current Genomics 2015; 16 (5) . https://dx.doi.org/10.2174/1389202916666150707155610